Compare SPDR Gold Trust (GLD) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SPDR Gold Trust vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? SPDR Gold Trust trades at $383.87 (market cap $141.59B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B). The key difference: SPDR Gold Trust is far larger — about 5.6× Royalty Pharma plc Class A Ordinary Shares's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while SPDR Gold Trust pays none. Which is the better fit depends on your goals — on Pluang, investors hold SPDR Gold Trust for 74 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| GLD | RPRX | |
|---|---|---|
Market Cap | $141.59B | $25.27B |
Volume | 7,008,541 | 3,671,183 |
52-Week High | $495.90 | $63.96 |
52-Week Low | $362.32 | $35.44 |
Typical Hold Time | 74 Days | 0 Days |
Sector | — | Health |
Enterprise Value | — | $32.50B |
Dividend Yield | — | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GLD is trading at $375.88, down 1.66% over the past 24 hours amid broader pressure from rising Treasury yields and a stronger U.S. dollar. The technical picture remains bearish with key support at $372 and resistance at $378. Recent news highlights gold's struggle to maintain momentum despite safe-haven demand, with weak payrolls data failing to spark a sustained rally.
The outlook for GLD remains challenged by persistent headwinds from elevated interest rates and dollar strength, though some analysts see tactical buying opportunities at current levels. Key risks include further Fed rate hikes and declining investor sentiment, while potential catalysts include geopolitical tensions and inflation concerns.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SPDR Gold Trust
GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.
Read more on GLD →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
